A plant-based topical targeting both inflammation and infection in atopic dermatitis, is now recruiting Australian patients for Phase 2 trials.

End of content
No more pages to load
A plant-based topical targeting both inflammation and infection in atopic dermatitis, is now recruiting Australian patients for Phase 2 trials.
End of content
No more pages to load